UCAR T-cell group

BIOLOGICAL3 trials

Sponsors

Zhejiang University

Conditions

Myasthenia GravisRelapsed / Refractory Autoimmune Hemolytic AnemiaSystemic Lupus Erythematosus

Early Phase 1

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Autoimmune Hemolytic Anemia

Not yet recruitingNCT06920446

Zhejiang UniversityRelapsed / Refractory Autoimmune Hemolytic Anemia

Start: 2025-04-03End: 2027-11-30Target: 18Updated: 2025-04-09

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus

RecruitingNCT06920433

Zhejiang UniversitySystemic Lupus Erythematosus

Start: 2025-04-08End: 2027-11-30Target: 18Updated: 2025-05-01

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis

Not yet recruitingNCT06933563

Zhejiang UniversityMyasthenia Gravis

Start: 2025-04-30End: 2027-11-30Target: 18Updated: 2025-04-18